By MATT McCORD Using opioids to treat acute pain is a lot like burning coal to power our homes. Both are legacy solutions from an earlier era. Both were once celebrated as breakthroughs. And both have since proven to be dirty, dangerous, and incredibly costly to clean up. Despite this, we continue to rely on…
The FDA approved Sanofi and Regeneron Pharmaceuticals drug Dupixent as a treatment for the inflammatory skin disorder chronic spontaneous urticaria. The regulatory decision comes two years after the agency turned down an application for the biologic drug in this indication. The post Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin…
Too many women have experienced the impacts of living with gynecological conditions while feeling dismissed and struggling to get care. Women deserve better, and as we collectively challenge outdated norms, we are beginning to see improvement. Still, there’s much more work to be done. The post Women’s Health is Having Its Moment – It’s Time for…
Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it’s encouraging that regulatory bodies and professional organizations are making recommendations and raising awareness among healthcare providers. The post Drug-Gene Testing: Key to Safer Cancer Treatment appeared first on MedCity News.
The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile supply chains. As providers prepare for higher expenses and potential shortages, experts warn that these policies could wosen care quality and force hospitals to make tough financial…
UnitedHealth Group’s shares fell by over 22% on Thursday after its first quarter earnings. This is largely due to challenges in its Medicare Advantage business. The post Why UnitedHealth Group’s Shares Have Taken a Tumble appeared first on MedCity News.
Tariffs on pharmaceuticals. First, President Trump has voiced his goal to impose tariffs on pharmaceutical products made overseas. The New York Times reports: Mr. Trump said in remarks to reporters on Monday that pharmaceutical tariffs would come in the “not too distant future.”“We don’t make our own drugs anymore,” Mr. Trump said. “The drug companies…
During his first news conference as Health and Human Services secretary, Robert F. Kennedy Jr. on April 16 ticked off things he thinks kids with autism will never do, including paying taxes, holding a job, and going on a date. Kennedy’s comments go against science and reality. This slide presentation first appeared on KFF Health…
Robert F. Kennedy Jr.’s rise to become secretary of the Department of Health and Human Services has some concerned that anti-vaccine policies are coming. If the nation’s top public health agency pulls support of vaccination, other healthcare stakeholders will need to step up to fill the vaccine messaging void. The post How the Health Sector…
Randy Bolyga, founder CEO of RXNT, built his medical software company without venture capital, relying instead on SBA loans and a conservative, cash-positive growth strategy. He believes many venture capital-backed healthcare startups fail because they chase rapid growth without sustainable business models or a deep understanding of the market. The post Why One Healthcare Founder…